An Updated Meta-Analysis of Fatal Adverse Events Caused by Bevacizumab Therapy in Cancer Patients
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference48 articles.
1. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial;J Bennouna;Lancet Oncol,2013
2. Bevacizumab added to neoadjuvant chemotherapy for breast cancer;HD Bear;N Engl J Med,2012
3. Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer;RS Herbst;J Clin Oncol,2007
4. Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial;RS Herbst;Lancet,2011
5. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial;B Escudier;Lancet,2007
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. VEGF as a Key Actor in Recurrent Respiratory Papillomatosis: A Narrative Review;Current Issues in Molecular Biology;2024-07-01
2. Cytotoxic effects of aptamer-doxorubicin conjugates in an ovarian cancer cell line;Biochimie;2023-01
3. Bleeding complications in patients with squamous cell carcinoma of the head and neck;Head & Neck;2021-06-12
4. Real-World Experience in Toxicity with Bevacizumab in Indian Cancer Patients;South Asian Journal of Cancer;2021-04
5. Bilateral adrenal haematoma complicated by adrenal insufficiency in a patient treated with bevacizumab;BMJ Case Reports;2021-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3